Translate
Janux Therapeutics Inc
About
Janux Therapeutics Inc (NASDAQ:JANX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 27 2026
Janux Therapeutics Announces Discontinuation of JANX008 Clinical Development
Apr 16 2026
Janux Therapeutics Announces First Participant Dosed in Phase 1 Study of JANX014
Apr 1 2026
Janux Therapeutics Announces Development Candidate Nomination Under Bristol Myers Squibb Collaboration, Triggering $35 Million Milestone Payment
Feb 26 2026
Janux Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Feb 17 2026
Janux Therapeutics Announces First Patient Dosed in Phase 1 Study of JANX011
Financials
Revenue
$10 M
Market Cap
$902.74 M
EPS
-1.83